Navigation Links
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Date:10/31/2011

lion, up 6%.  Platelet revenues continue to benefit from strong sales in emerging markets.

Red cell disposables revenue was $11.6 million, up 3%.  Red cell revenues grew due to increasing demand for red cells as the Company leveraged its IMPACT selling approach in the market.

Hospital

Surgical disposables revenue was $16.2 million, up 1%. The Elite® product launch is expected to accelerate in the second half of fiscal 12.  OrthoPAT orthopedic perioperative autotransfusion system disposables revenue was $7.3 million, down 12% and remains impacted by the voluntary recall of pre-2002 devices.

Diagnostics revenue was $5.7 million, up 22%.  Revenue growth related to the TEG® Thrombelastograph® Hemostasis Analyzer business was also driven by the Company's IMPACT initiative.

Software Solutions revenue was $17.2 million, up 7%.  The enhanced offering of software products for Blood Bank and Hospital customers continues to drive revenue growth.

Equipment and other revenue was $14.8 million, up 4% following a first quarter in which a 13% decline occurred.  Equipment revenues are influenced by the timing of tenders and capital budgets.

Haemonetics reported second quarter fiscal 12 revenue growth in all regions with sales up 10% in North America, 9% in Japan, 13% in Asia and 1% in Europe.

Cash Flow and Share Repurchase ActivityThe Company reported continued strong cash flows.  Excluding transformation costs in fiscal 12 and 11 and deal costs in fiscal 11, adjusted first half operating cash flow was $57.1 million, up 8%, and free cash flow was $33.4 million, up 15%.  During the second quarter of fiscal 12, the Company repurchased approximately 852,400 of its common shares in the open market, completing its authorized $50 million repurchase program.

GuidanceThe company now expects fiscal year 12 revenue growth of 6-7%, slightly above the high end of its previ
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
2. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
3. Haemonetics to Present at J.P. Morgan Healthcare Conference
4. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
5. Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
6. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
7. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
8. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2011
10. ERT Reports Third Quarter 2011 Operating Results
11. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015  Xcelience, a contract development ... has made a structured cash investment in Powdersize, ... in milling, micronization and powder size classification within ... Powdersize,s business while simultaneously adding a complete set ... of capabilities. "As we continue ...
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... Calif., Feb.16, 2012   HealthWarehouse.com , Inc. (OTC: HEWA), ... MedLion , Inc., a pioneering direct primary care ... and uninsured people in the Bay Area, Central Coast ... their homes. Nearly seven million Californians lacked ...
... KING OF PRUSSIA, Pa., Feb. 16, 2012 Medical ... the first fully-monitored medical alarm system that allows the ... today provides investors with an update on current initiatives. ... Inc. CFO and President, Ronald Adams. "We ...
Cached Medicine Technology:HealthWarehouse.com Partners With MedLion to Bring Affordable Healthcare to Northern California 2HealthWarehouse.com Partners With MedLion to Bring Affordable Healthcare to Northern California 3Medical Alarm Concepts Investor Update -- News on Current Initiatives 2Medical Alarm Concepts Investor Update -- News on Current Initiatives 3
(Date:7/31/2015)... ... July 31, 2015 , ... ... What are the STASH awards? The Significant Technological Achievements in Secretive Horticulture ... community as well as tried-and-true products that have stood the test of time. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source for authentic ... at Grant Park. The festival will end on Sunday, August 2nd. ... the annual Lollapalooza. This unique and unbelievably popular festival attracts the best in ...
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... Sculpted ... , the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator in ... in January 2014 for treating the outer thighs. The original applicator required a ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source ... launch three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and ... Prep from MDLinx makes preparing for the exam easy and painless. MDLinx offers ...
(Date:7/31/2015)... (PRWEB) , ... July 31, ... ... Jason T. Brown’s live lecture on pharmaceutical negligence is now available online ... was well received with a 94% approval rating from the nationwide audience. ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... , ST. LOUIS, Nov. 20 Centene ... will present at the Bank of America Merrill Lynch 2009 ... Crowne Plaza Hotel Times Square in New York City. , ... Time. Investors and other interested parties may access a live, ...
... Nov. 20 Samuel Gladding is no Scrooge, but he ... be "happy" during the holidays. As a licensed professional counselor ... Department of Counseling at Wake Forest University, Gladding says research ... often leads to sadness and even depression during the holidays. ...
... , , NEW YORK, Nov. ... announced that it will broadcast Doctor Radio Reports: What ... by veteran journalist Perri Peltz. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) , ... About Mammograms will air November 21 live at 10:00 ...
... durations of exposure to formaldehyde used for embalming in ... of death from myeloid leukemia, according to a new ... of the National Cancer Institute . Previous studies ... cancer in anatomists, pathologists, and funeral industry workers, all ...
... Washington) November 20, 2009Emergency medical service (EMS) providers ... cardiac arrests each year. Only 5 to ... arrest survive. Better quality cardiopulmonary resuscitation (CPR) ... with better patient outcome. The Resuscitation Outcomes ...
... short as 34 weeks, potentially adding to preemie delivery rate, experts ... that the rate of preterm deliveries continues to climb in the ... Many women are confused about what constitutes a full-term birth in ... the study considered a baby born at 34 to 36 weeks ...
Cached Medicine News:Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
For the quantitative in vitro determination of Urea in serum, plasma and urine....
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
Medicine Products: